productivity and grant awards; the clinical world is pressured by financial constraints and a focus purely on clinical output. Both are frustrated by the diminishing recognition of their 'value-added' contributions, in particular the forays of one world into the other. For our specialty to flourish and for continued improvements in our understanding of disease mechanisms and patient care, we need academics, clinicians and a spectrum of those with interest and expertise spanning the two. There is a risk that the current climate will push academic and clinical words apart; to prevent this, we need to forge new links between the two, whilst maintaining and nurturing existing ones; above all, we must have dialogue, and it is this philosophy that has led to the current 'Bed to Bedside' articles. To kick off, Dr. Kate Tatham describes how the group in which she works is studying the mechanisms involved in lung transplantation and ex vivo lung perfusion. I have invited similar articles from other research groups around the country (and beyond) which will appear in future issues but would very much welcome uninvited submissions along this theme.
Also in this issue, we have a wonderful selection of original articles from which certain themes appear to have evolved: trauma, rehabilitation from critical illness and the impact of critical illness on subsequent quality of life. In addition, Dr. Black and colleagues provide a valuable insight into the dosing of renal replacement therapy in Scottish intensive care units (ICUs); in so doing, they provide an approach that can be easily replicated and adopted in our own ICUs. It is important to recognise that sometimes the process of a study is as important (if not more so) as the result itself. Not all results can be extrapolated widely; however, a well-conducted process of research or evaluation can provide a 'recipe' for reviewing specific processes and outcomes that can be widely adopted; in so doing, we can gain valuable local insight into ways for improving patient care. In a similar vein, Anna Knott and colleagues describe their data on barriers to rehabilitation in ICU; while the process described is easily adopted, the comments in Eve Corner's editorial guide further refinement and raise interesting questions of barriers versus contraindications. If you are unsure whether rehabilitation is important at all, then the report in this issue of the qualitative arm of the PIX study makes for humbling reading.
In addition, you will find a systematic review of the implications of raised troponin levels in patients with sepsis and no angiographic evidence of coronary artery disease. The issue of raised troponins during critical illness remains a favourite topic for discussion during ward rounds and will likely remain so into the future; I'm not sure what we will debate if we ever develop a definitive biomarker of coronary vascular events -probably procalcitonin . . .
The above sit alongside the usual offerings of case reports, correspondence and opinion pieces; all of which will stimulate the brain cells and, I hope, your own contributions. It is worth emphasising that JICS (and the ICS) aims to represent all intensive care disciplines and professionals, and I hope the breadth of topics covered in this and other issues of the Journal reflect this. If you feel differently about this or any other JICS or ICU-related issues, then please put 'pen to paper' and let me know; 'you've got to be in it to win it' -and that includes the 2000 prize!
